Results 161 to 170 of about 18,494 (211)

Oral Vancomycin for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.

JAMA Netw Open
Keating JA, Xu T, Graham MB, Ramesh M, Khanna S, Dixon J, Kates A, Haight K, Zhao J, Saddler C, Safdar N.   +10 more
europepmc   +1 more source

Management and Outcomes of Clostridioides difficile Infection in Patients on Immune Checkpoint Inhibitors. [PDF]

J Natl Compr Canc Netw
Magahis PT, Satish D, Kamboj M, Babady NE, Baul J, Kalvin HL, Panageas K, Postow MA, Laszkowska M, Faleck DM.   +9 more
europepmc   +1 more source

Chronic Kidney Disease as a Predictor of Mortality in Hospitalized Inflammatory Bowel Disease Patients With Clostridioides difficile Infection. [PDF]

Cureus
Sleiman J, Gaballa A, Aslam T, Rizvi TA, El Sayegh S.   +4 more
europepmc   +1 more source

Evaluating Vancomycin Monotherapy and Dual Therapy with Nifuroxazide for Medium-Severe Clostridioides Difficile Infection. [PDF]

Antibiotics (Basel)
Rahimić J, Alibegović E, Lekić L, Boras MM, Džidić-Krivić A, Farhat EK, Sher EK.   +6 more
europepmc   +1 more source

Proton Pump Inhibitor Use and Risk of Clostridioides difficile Infection: An Umbrella Review of 11 Meta-Analyses. [PDF]

Cureus
Nalabothula S, Chava S, Doddapaneni NSP, Gottimukkala HSK, Durga D.   +4 more
europepmc   +1 more source

Age-targeted vaccination for reducing Clostridioides difficile infection in England: a coupled mathematical-economic modelling analysis. [PDF]

BMC Med
Yakob L, Allel K, Elragig A, Planche T, Mugwagwa T, Moïsi JC, Yu H.   +6 more
europepmc   +1 more source

Risk factors and outcomes of Clostridioides difficile infection in patients with colorectal cancer: critical perspective in management. [PDF]

Gut Pathog
Raeisi H, Patrizia S, Sadeghi A, Barbanti F, Tillotson G, Safarpour H, Zali M, Nazemalhosseini Mojarad E.   +7 more
europepmc   +1 more source